{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T07:19:58Z","timestamp":1777706398121,"version":"3.51.4"},"reference-count":48,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[1990,4,1]],"date-time":"1990-04-01T00:00:00Z","timestamp":638928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,7]],"date-time":"2015-12-07T00:00:00Z","timestamp":1449446400000},"content-version":"vor","delay-in-days":9381,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[1990,4]]},"DOI":"10.1038\/ki.1990.96","type":"journal-article","created":{"date-parts":[[2007,5,28]],"date-time":"2007-05-28T17:54:16Z","timestamp":1180374856000},"page":"1134-1141","source":"Crossref","is-referenced-by-count":25,"title":["Increased thromboxane biosynthesis in childhood hemolytic uremic syndrome"],"prefix":"10.1016","volume":"37","author":[{"given":"Burkhard","family":"T\u00f6nshoff","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rita","family":"Momper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. Gonne","family":"K\u00fchl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Horst","family":"Schweer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karl","family":"Sch\u00e4rer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hannsj\u00f6rg W.","family":"Seyberth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1038\/ki.1990.96_bb0010","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1136\/bmj.1.6061.599","article-title":"Presentation, management, complications, and outcome of acute renal failure in childhood: Five years experience","volume":"1","author":"Counaham","year":"1977","journal-title":"Br Med J"},{"key":"10.1038\/ki.1990.96_bb0015","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0031-3955(16)36467-7","article-title":"Cytotoxin-producing Escherichia coli and the hemolytic uremic syndrome","volume":"35","author":"Cleary","year":"1988","journal-title":"Pediatr Clin N Am"},{"key":"10.1038\/ki.1990.96_bb0020","first-page":"148","article-title":"The hemolytic uremic syndrome of childhood and its variants","volume":"24","author":"Kaplan","year":"1987","journal-title":"Sem Hematol"},{"key":"10.1038\/ki.1990.96_bb0025","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1182\/blood.V60.3.564.564","article-title":"Impairement of platelet aggregation in hemolytic uremic syndrome. Evidence for platelet exhaustion","volume":"60","author":"Fong","year":"1982","journal-title":"Blood"},{"key":"10.1038\/ki.1990.96_bb0030","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/ki.1988.17","article-title":"Intravascular platelet activation in the hemolytic uremic syndrome","volume":"33","author":"Walters","year":"1987","journal-title":"Kidney Int"},{"key":"10.1038\/ki.1990.96_bb0035","first-page":"110","article-title":"Prostacyclin in thrombotic mi croangiopathy","volume":"24","author":"Remuzzi","year":"1987","journal-title":"Sem Hematol"},{"key":"10.1038\/ki.1990.96_bb0040","first-page":"193","article-title":"Disturbances of prostacyclin metabolism in children with hemolytic uremic syndrome and in first degree relatives","volume":"25","author":"Turi","year":"1986","journal-title":"Clin Nephrol"},{"key":"10.1038\/ki.1990.96_bb0045","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1136\/adc.58.9.703","article-title":"Inhibitor of prostacyclin production in sporadic haemolytic uraemic syndrome","volume":"58","author":"Levin","year":"1983","journal-title":"Arch Dis Child"},{"key":"10.1038\/ki.1990.96_bb0050","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0022-3476(87)80344-X","article-title":"Absence of plasma prostacyclin stimulating activity deficiency in hemolytic uremic syndrome","volume":"111","author":"Schlegel","year":"1987","journal-title":"J Pediatr"},{"key":"10.1038\/ki.1990.96_bb0055","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1172\/JCI110814","article-title":"Endogenous synthesis of prostacyclin and thromboxane and platelet function during chronic administration of aspirin in man","volume":"71","author":"FitzGerald","year":"1983","journal-title":"J Clin Invest"},{"key":"10.1038\/ki.1990.96_bb0060","first-page":"15","article-title":"Thromboxane A2 biosynthesis and effects on platelets","volume":"10","author":"Granstr\u00f6m","year":"1982","journal-title":"Adv Prostagland Thromb Leuk Res"},{"key":"10.1038\/ki.1990.96_bb0065","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/S0022-3476(85)80243-2","article-title":"Prostanoids in hemolytic uremic syndrome","volume":"106","author":"Stuart","year":"1985","journal-title":"J Pediatr"},{"key":"10.1038\/ki.1990.96_bb0070","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1161\/01.CIR.67.6.1174","article-title":"Analysis of prosta cyclin and thromboxane biosynthesis in cardiovascular disease","volume":"67","author":"FitzGerald","year":"1983","journal-title":"Circulation"},{"key":"10.1038\/ki.1990.96_bb0075","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/BF00981128","article-title":"Determination of peripheral plasma prostanoid concentration: An unreliable index of \u2018in vivo\u2019 prostanoid activity","volume":"31","author":"Schweer","year":"1986","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1038\/ki.1990.96_bb0080","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1161\/01.CIR.73.6.1300","article-title":"Increased thromboxane biosynthesis in a human model of platelet activation: Biochemical and functional consequences of selective inhibition of thromboxane synthase","volume":"73","author":"Reilly","year":"1986","journal-title":"Circulation"},{"key":"10.1038\/ki.1990.96_bb0085","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/0049-3848(87)90103-4","article-title":"Paired analysis of urinary throm boxane B2 metabolites in humans","volume":"47","author":"Catella","year":"1987","journal-title":"Thromb Res"},{"key":"10.1038\/ki.1990.96_bb0090","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1172\/JCI112053","article-title":"Functional significance of renal prostacyclin and thromboxane A2 production in patients with systemic lupus erythematosus","volume":"76","author":"Patrono","year":"1985","journal-title":"J Clin Invest"},{"key":"10.1038\/ki.1990.96_bb0095","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/0003-2697(86)90247-2","article-title":"Long-lived enzymatic metabolites of thromboxane B2 in the human circulation","volume":"155","author":"Lawson","year":"1986","journal-title":"Anal Biochem"},{"key":"10.1038\/ki.1990.96_bb0100","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/0003-2697(87)90380-0","article-title":"Tandem mass spectrometric determination of 11-dehydro-throm-boxane-B2, an index metabolite of thromboxane B2 in plasma and urine","volume":"164","author":"Schweer","year":"1987","journal-title":"Anal Biochem"},{"key":"10.1038\/ki.1990.96_bb0105","doi-asserted-by":"crossref","first-page":"5861","DOI":"10.1073\/pnas.83.16.5861","article-title":"11-dehydro-thromboxane B2: A quantitative index of thromboxane A2 biosyn thesis in the human circulation","volume":"83","author":"Catella","year":"1986","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/ki.1990.96_bb0110","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1172\/JCI110373","article-title":"Estimated rate of prostacyclin secretion into the circulation in normal man","volume":"68","author":"FitzGerald","year":"1981","journal-title":"J Clin Invest"},{"key":"10.1038\/ki.1990.96_bb0115","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0002-9343(86)90905-8","article-title":"Measurement of renal and non-renal eicosanoid synthesis","volume":"81","author":"Catella","year":"1986","journal-title":"Am J Med"},{"key":"10.1038\/ki.1990.96_bb0120","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1136\/adc.59.5.397","article-title":"Haemolytic uraemic syndrome","volume":"59","author":"Levin","year":"1984","journal-title":"Arch Dis Child"},{"key":"10.1038\/ki.1990.96_bb0125","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/BF01476776","article-title":"Endotheliotropic (hemolytic) nephroangiopathy and its various manifestation forms (thrombotic microangiopathy, primary malignant nephrosclerosis, hemolytic-uremic syndrome)","volume":"58","author":"Thoenes","year":"1980","journal-title":"Klin Wochenschr"},{"key":"10.1038\/ki.1990.96_bb0130","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1203\/00006450-198406000-00007","article-title":"Urinary excretion rates of 6-keto-PGFl\u03b1 in preterm infants recovering from respiratory distress with and without patent ductus arteriosus","volume":"18","author":"Seyberth","year":"1984","journal-title":"Pediatr Res"},{"key":"10.1038\/ki.1990.96_bb0135","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/S0378-4347(00)86079-X","article-title":"Improved sample preparation for the quantitative mass spectrometric determination of prostaglandins in biological samples","volume":"226","author":"M\u00fcller","year":"1981","journal-title":"J Chromatogr"},{"key":"10.1038\/ki.1990.96_bb0140","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/0003-2697(81)90018-X","article-title":"Quantitative analysis of two dinor urinary metabolites of prostaglandin I2","volume":"115","author":"Falardeau","year":"1981","journal-title":"Anal Biochem"},{"key":"10.1038\/ki.1990.96_bb0145","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/0003-2697(85)90536-6","article-title":"Measure ment of urinary 2,3-dinor-thromboxane B2 and thromboxane B2 using bonded-phase phenylboronic acid columns and capillary gas chromatography-negative-ion chemical ionization mass spectrome try","volume":"150","author":"Lawson","year":"1985","journal-title":"Anal Biochem"},{"key":"10.1038\/ki.1990.96_bb0150","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/0003-2697(87)90380-0","article-title":"Tandem mass spectrometric determination of 11-dehydro-throm-boxane B2 in plasma and urine","volume":"164","author":"Schweer","year":"1987","journal-title":"Anal Biochem"},{"key":"10.1038\/ki.1990.96_bb0155","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S0022-3476(78)80601-5","article-title":"Geometric method for measuring body surface area: A height-weight formula validated in infants, children and adults","volume":"93","author":"Haycock","year":"1978","journal-title":"J Pediatr"},{"key":"10.1038\/ki.1990.96_bb0160","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/S0022-3476(64)80337-1","article-title":"The hemolytic-uremic syndrome","volume":"64","author":"Gianantonio","year":"1964","journal-title":"J Pediatr"},{"key":"10.1038\/ki.1990.96_bb0165","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0022-3476(73)80364-6","article-title":"Platelet, erythrocyte, and fibrinogen kinetics in the hemolytic uremic syndrome of infancy","volume":"83","author":"Katz","year":"1973","journal-title":"J Pediatr"},{"key":"10.1038\/ki.1990.96_bb0170","first-page":"207","article-title":"Intraplatelet serotonin in children with the hemolytic uremic syndrome","volume":"23","author":"Edefanti","year":"1985","journal-title":"Clin Nephrol"},{"key":"10.1038\/ki.1990.96_bb0175","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1172\/JCI112341","article-title":"Estimated rate of thromboxane secretion into the circulation of normal humans","volume":"77","author":"Patrono","year":"1986","journal-title":"J Clin Invest"},{"key":"10.1038\/ki.1990.96_bb0180","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/0090-6980(76)90125-8","article-title":"Arterial walls generate from prostaglandin endoperoxides a substance (prosta glandin X) which relates strips of mesenteric and coeliac arteries and inhibits platelet aggregation","volume":"12","author":"Bunting","year":"1976","journal-title":"Prostaglandin"},{"key":"10.1038\/ki.1990.96_bb0185","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1093\/oxfordjournals.bmb.a071482","article-title":"Unstable metabolites of arachidonic acid and their role in haemostasis and thrombosis","volume":"34","author":"Moncada","year":"1978","journal-title":"Br Med Bull"},{"key":"10.1038\/ki.1990.96_bb0190","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/0090-6980(82)90118-6","article-title":"Prostacyclin is not a circulating hormone in man","volume":"23","author":"Blair","year":"1982","journal-title":"Prostaglandins"},{"key":"10.1038\/ki.1990.96_bb0195","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1172\/JCI113895","article-title":"Redirection of prostaglandin endo-peroxide metabolism at the platelet-vascular interface in man","volume":"83","author":"Nowak","year":"1989","journal-title":"J Clin Invest"},{"key":"10.1038\/ki.1990.96_bb0200","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1056\/NEJM198404263101701","article-title":"Increased prostacyclin biosynthesis in patients with severe atherosclerosis and platelet activation","volume":"310","author":"FitzGerald","year":"1984","journal-title":"N Engl J Med"},{"key":"10.1038\/ki.1990.96_bb0205","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1056\/NEJM198610163151602","article-title":"Platelet activation in unstable coronary disease","volume":"315","author":"Fitzgerald","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1038\/ki.1990.96_bb0210","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1136\/bmj.292.6527.1037","article-title":"Biosynthesis of thrombox ane in patients with systemic sclerosis and Raynaud's phenomenon","volume":"292","author":"Reilly","year":"1986","journal-title":"Br Med J"},{"key":"10.1038\/ki.1990.96_bb0215","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1136\/adc.59.12.1135","article-title":"Abnormalities of factor VIII related protein multimers in the haemolytic uraemic syndrome","volume":"59","author":"Rose","year":"1984","journal-title":"Arch Dis Child"},{"key":"10.1038\/ki.1990.96_bb0220","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S0022-3476(80)80210-1","article-title":"Aspirin and dipyridamole therapy in the hemolytic-uremic syndrome","volume":"97","author":"O'Regan","year":"1980","journal-title":"J Pediatr"},{"key":"10.1038\/ki.1990.96_bb0225","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S0022-3476(88)80031-3","article-title":"Heparin plus dipyridamole in childhood hemolytic-uremic syndrome: A prospective randomized study","volume":"113","author":"Van Damme-Lombaerts","year":"1988","journal-title":"J Pediatr"},{"key":"10.1038\/ki.1990.96_bb0230","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/S0140-6736(78)91269-2","article-title":"Dipyridamole and other phosphodiester ase inhibitors act as antithrombotic agents by potentiating endoge nous prostacyclin","volume":"1","author":"Moncada","year":"1978","journal-title":"Lancet"},{"key":"10.1038\/ki.1990.96_bb0235","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/ki.1987.206","article-title":"HUS and TTP: Variable expression of a single entity","volume":"32","author":"Remuzzi","year":"1987","journal-title":"Kidney Int"},{"key":"10.1038\/ki.1990.96_bb0240","first-page":"130","article-title":"Antiplatelet therapy in thrombotic thrombocy topenic purpura","volume":"24","author":"Del Zoppo","year":"1987","journal-title":"Sem Hematol"},{"key":"10.1038\/ki.1990.96_bb0245","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/ki.1986.210","article-title":"Roles for thromboxane A2 and leukotrienes in endotoxin-induced acute renal failure","volume":"30","author":"Badr","year":"1986","journal-title":"Kidney Int"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815348614?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815348614?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,10,29]],"date-time":"2021-10-29T20:02:50Z","timestamp":1635537770000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253815348614"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1990,4]]},"references-count":48,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1990,4]]}},"alternative-id":["S0085253815348614"],"URL":"https:\/\/doi.org\/10.1038\/ki.1990.96","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[1990,4]]}}}